| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.30▲ | 7.35▼ | 7.35▼ | 7.47▼ | 7.81▼ |
| MA10 | 7.30▲ | 7.38▼ | 7.39▼ | 7.56▼ | 8.47▼ |
| MA20 | 7.33▼ | 7.41▼ | 7.39▼ | 7.99▼ | 8.25▼ |
| MA50 | 7.37▼ | 7.43▼ | 7.50▼ | 8.58▼ | 10.22▼ |
| MA100 | 7.39▼ | 7.51▼ | 7.80▼ | 8.39▼ | 11.09▼ |
| MA200 | 7.39▼ | 7.83▼ | 8.38▼ | 10.09▼ | 20.33▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.008▼ | -0.002▼ | -0.058▼ | -0.041▼ |
| RSI | 44.589▼ | 42.723▼ | 43.340▼ | 31.116▼ | 34.823▼ |
| STOCH | 34.624 | 27.567 | 41.911 | 13.632▼ | 24.852 |
| WILL %R | -55.000 | -79.070▼ | -68.519 | -93.662▼ | -96.429▼ |
| CCI | -10.411 | -125.487▼ | -100.626▼ | -83.224 | -139.746▼ |
|
Thursday, October 01, 2026 09:01 AM
Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that novel biomarker data from a Phase 1 ...
|
|
Thursday, September 24, 2026 05:00 PM
日本１０年利回り3.0770-0.16%ネガティブ 米国債１０年利回り5.1709 +0.17%ポジティブ ドイツ１０年利回り3.6061-0.47%ネガティブ 英国債１０年5.3528-0.24%ネガティブ 掲載の情報は15分以上の遅れで表示しています。詳しくはこちらをご確認ください。
|
|
Sunday, August 09, 2026 05:00 PM
Evercore ISI Group analyst Jonathan Miller maintains Arvinas (NASDAQ:ARVN) with a Outperform and lowers the price target from $19 to $14. Citigroup analyst Yigal Nochomovitz maintains Arvinas ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/10/26 | 7.49 | 7.49 | 7.275 | 7.31 | 579,777 |
| 05/10/26 | 7.46 | 7.505 | 7.22 | 7.46 | 625,857 |
| 02/10/26 | 7.51 | 7.52 | 7.30 | 7.41 | 585,115 |
| 01/10/26 | 7.74 | 7.82 | 7.43 | 7.43 | 807,321 |
| 30/09/26 | 7.55 | 8.04 | 7.442 | 7.735 | 1,061,018 |
| 29/09/26 | 7.49 | 7.52 | 7.36 | 7.50 | 496,012 |
| 28/09/26 | 7.54 | 7.565 | 7.38 | 7.51 | 512,058 |
| 25/09/26 | 7.78 | 7.81 | 7.535 | 7.59 | 713,363 |
| 24/09/26 | 7.81 | 7.819 | 7.39 | 7.79 | 1,218,007 |
| 23/09/26 | 8.60 | 8.64 | 7.815 | 7.83 | 761,233 |
|
|
||||
|
|
||||
|
|